CATALOGO DEI PRODOTTI DELLA RICERCA

CIPRIANI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.581
EU - Europa 9.003
AS - Asia 6.514
SA - Sud America 1.102
AF - Africa 157
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 27.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.421
SG - Singapore 2.803
RU - Federazione Russa 2.747
GB - Regno Unito 2.381
CN - Cina 1.712
IT - Italia 1.168
BR - Brasile 877
VN - Vietnam 623
FR - Francia 599
HK - Hong Kong 582
FI - Finlandia 482
DE - Germania 481
IE - Irlanda 387
SE - Svezia 347
KR - Corea 219
UA - Ucraina 160
BD - Bangladesh 116
AR - Argentina 85
CA - Canada 80
IN - India 73
NL - Olanda 62
TR - Turchia 60
ID - Indonesia 54
NG - Nigeria 52
JP - Giappone 44
MX - Messico 43
IQ - Iraq 34
PK - Pakistan 33
EC - Ecuador 32
AT - Austria 28
ZA - Sudafrica 28
ES - Italia 27
AU - Australia 24
PL - Polonia 24
IL - Israele 23
CO - Colombia 20
PY - Paraguay 20
RO - Romania 19
BE - Belgio 18
UY - Uruguay 18
PH - Filippine 17
SA - Arabia Saudita 16
CL - Cile 15
VE - Venezuela 15
PE - Perù 14
KE - Kenya 13
MA - Marocco 13
AZ - Azerbaigian 12
JO - Giordania 12
EG - Egitto 11
CH - Svizzera 9
DZ - Algeria 9
EU - Europa 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
HU - Ungheria 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
KZ - Kazakistan 7
CR - Costa Rica 6
JM - Giamaica 6
LT - Lituania 6
GT - Guatemala 5
HN - Honduras 5
IR - Iran 5
NP - Nepal 5
PT - Portogallo 5
AM - Armenia 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
KG - Kirghizistan 4
MY - Malesia 4
OM - Oman 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
AO - Angola 3
BB - Barbados 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
LB - Libano 3
RS - Serbia 3
SI - Slovenia 3
UG - Uganda 3
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SC - Seychelles 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
Totale 27.369
Salva come PNG Salva come JPEG
Città #
Southend 2.103
Singapore 1.477
Jacksonville 1.302
Woodbridge 967
Chandler 841
San Jose 838
Ashburn 830
Moscow 738
Dallas 686
Ann Arbor 580
Hong Kong 574
Houston 557
Dublin 387
Verona 375
The Dalles 332
Beijing 284
Council Bluffs 267
Wilmington 222
Lawrence 216
Princeton 216
Ho Chi Minh City 202
New York 185
Los Angeles 132
Nanjing 128
Hanoi 127
Milan 113
Jinan 112
Buffalo 108
Shenyang 104
São Paulo 78
Hebei 73
Redondo Beach 61
Helsinki 58
Munich 58
Santa Clara 58
Dong Ket 56
Tianjin 53
Rome 51
Changsha 49
Abuja 48
Sindelfingen 47
Nanchang 45
Boardman 42
Haikou 40
Guangzhou 38
Hangzhou 38
Ningbo 36
Columbus 35
Orem 35
Washington 34
London 32
Tokyo 32
Norwalk 31
Dearborn 30
Redwood City 30
Toronto 30
Zhengzhou 30
San Francisco 29
Taiyuan 29
Bologna 28
Frankfurt am Main 28
Jiaxing 26
Chicago 25
Taizhou 25
Manchester 24
Turku 24
Mexico City 22
Naples 22
Haiphong 21
Lancaster 21
Shanghai 21
Belo Horizonte 20
Florence 20
Da Nang 19
Rio de Janeiro 19
Stockholm 19
Amsterdam 18
Atlanta 18
Brasília 18
Brooklyn 17
Jakarta 17
Montreal 17
Chennai 16
Montevideo 16
Barnet 15
Brussels 15
Fuzhou 15
Warsaw 15
Nuremberg 14
Vienna 14
Düsseldorf 13
Falls Church 13
Guayaquil 13
Johannesburg 13
Porto Alegre 13
Campinas 12
Curitiba 12
Denver 12
Dhaka 12
Lanzhou 12
Totale 17.043
Salva come PNG Salva come JPEG
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 609
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 412
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 308
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials 262
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 248
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 243
Antidepressants and benzodiazepines for panic disorder in adults 221
Assessing risk of bias in randomized controlled trials 198
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 197
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 194
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 194
Azapirones versus placebo for panic disorder in adults 192
Allocation concealment and blinding in clinical trials 191
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 189
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 186
"Wish bias" in antidepressant drug trials? 185
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 185
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 183
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 183
Antidepressive Monotherapie 179
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 179
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 178
Sertraline versus other antidepressive agents for depression 178
Are all antidepressants really the same? The case of fluoxetine: a systematic review 172
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 171
Agomelatine and the brave old world of narrative-based medicine 170
Benzodiazepines and risk of dementia: true association or reverse causation? 169
Imputing missing standard deviations in meta-analyses can provide accurate results 167
What is a run-in phase? 167
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 166
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 164
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 164
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 163
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 163
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 163
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 163
Citalopram versus other anti-depressive agents for depression. 163
A primer on network meta-analysis with emphasis on mental health 163
Implementation of treatment guidelines for specialist mental health care 163
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 161
Antidepressants for Bipolar Disorder 160
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis 160
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 160
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 159
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis 159
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 158
Citalopram versus other anti-depressive agents for depression 157
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 154
Citalopram versus other anti-depressive agents for depression 154
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development 152
Duloxetine versus other anti-depressive agents for depression 150
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 149
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 149
Randomized trials published in Chinese or Western journals: comparative empirical analysis 149
Associazione tra TCA e SSRI nella depressione resistente 148
What is a systematic review? 148
Implementation of treatment guidelines for specialist mental health care 144
Seven criteria for improving effectiveness trials in psychiatry 143
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 143
Antidepressants in unipolar major depression: what we need to know 143
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis 142
Sertraline versus other antidepressive agents for depression 142
Levels of evidence: can quality of systematic reviews be quantified? 140
Advancing evidence-based practice to improve patient care 140
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 140
Outcome reporting bias in clinical trials 139
What is a risk ratio? 137
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 137
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 137
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 137
Paroxetine versus other anti-depressive agents for depression 136
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 136
What is a forest plot? 135
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 135
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 135
Implementation of treatment guidelines for specialist mental health care 135
Depressive disorders 134
Does the addiction of a second antipsychotic drug improve clozapine treatment? 133
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 132
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 131
Conventional vs. atypical antipsychotic medications [Letter] 130
Fluoxetine versus other types of pharmacotherapy for depression (Review) 130
Escitalopram versus other antidepressive agents for depression 129
Superiority, equivalence or non-inferiority? 128
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis 128
What is a Cochrane review? 127
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 125
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 122
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia 122
Does randomised evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis 122
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis 122
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 121
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 121
International dose differences in fluoxetine clinical trials conducted in patients with depression 121
What is a clinical trial protocol? 120
Conceptual and technical challenges in network meta-analysis 120
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis 119
Haloperidol alone or in combination for acute mania 118
Mirtazapine versus other antidepressive agents for depression 118
Validity of the impact factor of journals as a measure of randomised controlled trial quality 117
Totale 16.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.988
article - articoli 87.401
book - libri 386
conference - conferenze 0
curatela - curatele 0
other - altro 2.323
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.878
Totale 185.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20253.814 285 251 171 554 177 137 216 178 566 280 225 774
2025/202610.034 768 624 838 1.487 2.201 645 964 604 827 455 247 374
2026/2027278 278 0 0 0 0 0 0 0 0 0 0 0
Totale 27.524